Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지사와 도모끼찌로, 후지사와 야꾸힝고교 가부시끼가이샤filedCritical후지사와 도모끼찌로
Publication of KR930000116ApublicationCriticalpatent/KR930000116A/en
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (6)
활성 성분으로서 하기 일반식의 화합물을 담체와 혼합하여 함유하는 돼지 흉막 폐렴 예방/치료 조성물.A pig pleural pneumonia prevention / treatment composition comprising, as an active ingredient, a compound of the following general formula mixed with a carrier.식중, R은 벤조일기 또는 시클로헥산 카르보닐기이다.In the formula, R is a benzoyl group or a cyclohexane carbonyl group.돼지에게 활성 성분으로서 하기 일반식의 화합물을 담체와 혼합하여 투여함을 특징으로 하는 돼지 흉막 폐렴 예방 및 치료 방법.A method of preventing and treating swine pleural pneumonia, which is administered to a pig by mixing a compound of the following general formula as an active ingredient with a carrier.식중, R은 벤조일기 또는 시클로헥산 카르보닐기이다.In the formula, R is a benzoyl group or a cyclohexane carbonyl group.돼지 흉막 폐렴을 예방 또는 치료하기 위한 의약 제조용 하기 일반식의 화합물의 용도.Use of a compound of the general formula for the manufacture of a medicament for preventing or treating swine pleural pneumonia.식중, R은 벤조일기 또는 시클로헥산 카르보닐기이다.In the formula, R is a benzoyl group or a cyclohexane carbonyl group.제1항에 있어서, 일반식 중의 R 이 벤조일기인 돼지 흉막 폐렴 예방/치료 조성물.The composition for preventing / treating swine pleural pneumonia according to claim 1, wherein R in the general formula is a benzoyl group.제2항에 있어서, 일반식 중의 R이 벤조일기인 돼지 흉막 폐렴 예방 및 치료 방법.The method for preventing and treating swine pleural pneumonia according to claim 2, wherein R in the general formula is a benzoyl group.제3항에 있어서, 일반식 중의 R이 벤조일기인 화합물의 돼지 흉막 폐렴 예방 또는 치료용 의약 제조 용도.The pharmaceutical production use for the prevention or treatment of porcine pleural pneumonia according to claim 3, wherein the compound in the formula is R is a benzoyl group.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
Use of elliprodil and its enantiomers for the manufacture of a medicament useful for the prevention of peripheral neuropathy caused by anticancer agents